Interleukin-10 promotes anticollagen antibody production in type I diabetic peripheral B lymphocytes

Journal of Periodontal Research

Volumn 32, Issue 1 PART 2, 1997, Pages 189-195

  Stein, S H ^a   Hart, T E ^b   Hoffman, W H ^a   Hendrix, C L ^a   Gustke, C J ^a   Watson, S C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibody; Interleukin 10; Periodontitis; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; CD19 ANTIGEN; CD5 ANTIGEN; COLLAGEN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; CASE CONTROL STUDY; CELL SEPARATION; CHEMISTRY; CHILD; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MONONUCLEAR CELL; PERIODONTITIS; PORPHYROMONAS GINGIVALIS;

ADOLESCENT; ADULT; ANTIGENS, CD19; ANTIGENS, CD5; AUTOANTIBODIES; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CELL SEPARATION; CHILD; COLLAGEN; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS;

EID: 0030632041     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1997.tb01404.x     Document Type: Article

References (35)

1. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994; 65: 260-267.
2. Grossi SG, Genco RJ, Machtei EE, et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995; 66: 23-29.
3. Cianciola LJ, Park BH, Bruck E, et al. Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). J Am Dent Ass 1982; 104: 653-660.
4. Hugoson A, Thorstensson H, Falk H, et al. Periodontal conditions in insulin-dependent diabetics. J Clin Periodontol 1989; 16: 215-223.
5. Karjalainen KM, Knuuttila M, von Dickhoff KJ. Association of the severity of periodontal disease with organ complications in type 1 diabetic patients. J Periodontol 1994; 65: 1067-1072.
6. Tervonen T, Knuuttila M. Relation of diabetes control to periodontal pocketing and alveolar bone level. Oral Med Oral Surg Oral Path 1986; 61: 346-349.
7. Hayden P, Buckley LA. Diabetes mellitus and periodontal disease in an Irish population. J Periodont Res 1989; 24: 298-302.
8. Anusaksathien O, Dolby AE. Autoimmunity in periodontal disease. J Oral Pathol Med 1991; 20 101-107.
9. Govze Y, Herzberg MC. Serum and gingival crevicular fluid anti-desmosomal antibodies in periodontitis. J Periodont 1993; 64: 603-608.
10. Wassenaar A, Reinhardus C, Thepen T, et al. Cloning, characterization, and antigen specificity of T-lymphocyte subsets extracted from gingival tissue of chronic adult periodontitis patients. Infect Immun 1995; 63: 2147-2153.
11. Gargiulo Jr AV, Robinson J, Toto PD, et al. Identification of rheumatoid factor in periodontal disease. J Periodont 1982; 53: 568-577.
12. Ftis A, Singh G, Dolby AE. Antibody to collagen type I in periodontal disease. J Periodont 1986; 57: 693-699.
13. Hirsch HZ, Tarkowski A, Miller EJ, et al. Autoimmunity to collagen in adult periodontal disease. J Oral Path 1988; 17: 456-459.
14. Hayakawa K, Hardy RR, Honda M, et al. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibody. Proc Natl Acad Sci 1984; 81: 2494-2498.
15. Sugawara M, Yamashita K, Yoshie H. et al. Detection of, and anti-collagen antibody produced by. CD5-positive B cells in inflamed gingival tissue. J Periodont Res 1992; 27: 489-498.
16. O' Garra A, Chang R, Go N, et al. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992; 22: 711-717.
17. Stein SH, Harrell JC. IL-10 production by gingival mononuclear cells. J Dent Res 1994; 73: 378 (2211).
18. Ishida H, Hastings R, Kearney J. et al. Continuous antiinterleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 1992; 175: 1213-1220.
19. Ishida H, Muchamuel T, Sakaguchi S, et al. Continuous administration of anti-IL-10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994; 179: 305-310.
20. Wogensen L, Lee MS, Sarvetnick N. Production of interleukin-10 by islet cells accelerates immune-mediated destruction of cells in nonobesc mice. J Exp Med 1994; 179: 1379-1384.
21. Kalmar JR, Arnold RR, Warbington ML. Superior leukocyte separation with a discontinuous one-step Ficoll-Hypaque gradient for the isolation of human neutrophils. J Immunol Meth 1988; 110: 275-281.
22. 2 regulates gingival mononuclear cell immunoglobulin production. J Periodontol 1995; 66: 222-227.
23. Czerkinsky C, Nilsson LA, Nygren H, et al. A solid phase enzyme linked immunospot assay (ELISPOT) for enumeration of specific antibody-secreting cells. J Immunol Meth 1983 65: 109-118.
24. Jonsson R, Pitts A, Lue C, et al Immunoglobulin isotype distribution of locally produced autoantibodies to collagen type I in adult periodontitis. J Clin Periodontol 1991; 18: 703-707.
25. Llorente L, Richaud-Patin Y, Wijdenes J, et al Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993, 4: 421-430.
26. Llorente L, Richaud-Patin Y, Fior R. et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arth Rheum 1994; 37: 1647-1655.
27. Llorente L, Weiping Z, Levy Y, et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181: 839-844.
28. Ohno Y, Aoki N, Nishimura A. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-α in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 77: 1072-1077.
29. Molvig J, Pociot F, Baek L, et al. Monocyte function in IDDM patients and healthy individuals. Scand J Immunol 1990; 32: 297-311.
30. Offenbacher S, Collins JG, Yalda B, et al. Role of prostaglandins in high-risk periodontitis patients. In: Genco R, Hamada S, Lehner T, et al. eds. Molecular pathogenesis of periodontal disease. Washington DC: ASM Press, 1994; 203-214.
31. Staslny P, Ball EJ, Dry PJ, et al. The human immune response region (HLA-D) and disease susceptibility. Immunol Rev 1983; 70: 113-153.
32. Todd JA. Genetic control of autoimmunity in Type I diabetes. Immunol Today 1990; 11: 122-129.
33. Katz J, Goultschin J, Benoliel R, et al. Human leukocyte antigen (HLA) DR4 positive association with rapidly progressing periodontitis. J Periodont 1987; 58: 607-610.
34. Seagren-Alley C, Reinhardt RA, Maze CA, et al. HLA-D and T lymphocyte reactivity to specific periodontal pathogens in type I diabetic periodontitis. J Periodontol 1993; 64: 974-979.
35. Yalda B, Offenbacher S, Collins JG. Diabetes as a modifier of periodontal disease espression. Periodontol 2000 1994; 6: 37-49.